PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients

Podobne zapisy

• PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
  od: Consolaro, A, i wsp.
  Wydane: (2013)
• Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients
  od: Verazza, Sara, i wsp.
  Wydane: (2014)
• PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
  od: Negro, G, i wsp.
  Wydane: (2013)
• PReS-FINAL-2028: ANA positivity and a younger age at onset, but not disease category, predict the risk of uveitis in italian children with juvenile idiopathic arthritis
  od: Schiappapietra, B, i wsp.
  Wydane: (2013)
• PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis
  od: Falcini, F, i wsp.
  Wydane: (2013)